Living Cell Technologies Receives Diabetes Grant
Living Cell Technologies Receives Grant from the Juvenile Diabetes Research Foundation International for DIABECELL® NZ Clinical Trial
Living Cell Technologies Receives Grant from the Juvenile Diabetes Research Foundation International for DIABECELL® NZ Clinical Trial
Net operating cash outflows were $1,257,133 compared to $1,676,991 last quarter.
Roberts Biosolutions Ltd
Hillcoat Place, Edinburgh
United Kingdom
Email: info@genetherapyreview.com
Twitter: @gentherev